US FDA flags manufacturing lapses at Dabur's Silvassa plant; company issues clarification

US FDA flags manufacturing lapses at Dabur's Silvassa plant; company issues clarification

Dabur India has come under scrutiny after the United States Food and Drug Administration (US FDA) reportedly identified several deficiencies at one of the company's manufacturing facilities located at Silvassa in Dadra and Nagar Haveli. The observations relate to maintenance practices, data integrity concerns and manufacturing processes, raising questions about compliance standards at the plant. The findings stem from an inspection conducted by …